Stable Incretin Mimetics Counter Rapid Deterioration of Bone Quality in Type 1 Diabetes Mellitus
- 27 May 2015
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 230 (12) , 3009-3018
Abstract
Type 1 diabetes mellitus is associated with a high risk for bone fractures. Although bone mass is reduced, bone quality is also dramatically altered in this disorder. However, recent evidences suggest a beneficial effect of the glucose‐dependent insulinotropic polypeptide (GIP) and glucagon‐like peptide 1 (GLP‐1) pathways on bone quality. The aims of the present study were to conduct a comprehensive investigation of bone strength at the organ and tissue level; and to ascertain whether enzyme resistant GIP or GLP‐1 mimetic could be beneficial in preventing bone fragility in type 1 diabetes mellitus. Streptozotocin‐treated mice were used as a model of type 1 diabetes mellitus. Control and streptozotocin‐diabetic animals were treated for 21 days with an enzymatic‐resistant GIP peptide ([D‐Ala2]GIP) or with liraglutide (each at 25 nmol/kg bw, ip). Bone quality was assessed at the organ and tissue level by microCT, qXRI, 3‐point bending, qBEI, nanoindentation, and Fourier‐transform infrared microspectroscopy. [D‐Ala2]GIP and liraglutide treatment did prevent loss of whole bone strength and cortical microstructure in the STZ‐injected mice. However, tissue material properties were significantly improved in STZ‐injected animals following treatment with [D‐Ala2]GIP or liraglutide. Treatment of STZ‐diabetic mice with [D‐Ala2]GIP or liraglutide was capable of significantly preventing deterioration of the quality of the bone matrix. Further studies are required to further elucidate the molecular mechanisms involved and to validate whether these findings can be translated to human patients. J. Cell. Physiol. 230: 3009–3018, 2015.Keywords
Funding Information
- University of Angers
- University of Ulster Research Challenge
- University of Ulster Proof of Principle Funding Programs
This publication has 53 references indexed in Scilit:
- Incretin Action in the Pancreas: Potential Promise, Possible Perils, and Pathological PitfallsDiabetes, 2013
- Standardized nomenclature, symbols, and units for bone histomorphometry: A 2012 update of the report of the ASBMR Histomorphometry Nomenclature CommitteeJournal of Bone and Mineral Research, 2012
- Guidelines for assessment of bone microstructure in rodents using micro–computed tomographyJournal of Bone and Mineral Research, 2010
- Postprandial bone turnover is independent of calories above 250 kcalAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2010
- Poor glycemic control is associated with low BMD detected in premenopausal women with type 1 diabetesOsteoporosis International, 2008
- Interactions between microenvironment and cancer cells in two animal models of bone metastasisBritish Journal of Cancer, 2008
- FT-IR imaging of native and tissue-engineered bone and cartilageBiomaterials, 2007
- The effects of vanadium treatment on bone in diabetic and non-diabetic ratsBone, 2006
- Diabetes mellitus and the incidence of hip fracture: results from the Nord-Trøndelag Health SurveyDiabetologia, 1999
- Abnormal plasma glucose and insulin responses in heterozygous lean (ob/+) miceDiabetologia, 1981